Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. 1995

D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
Health and Ecological Assessment Division, Lawrence Livermore National Laboratory, University of California, Livermore 94550.

Heterocyclic amines (HAs) are formed as pyrolysis products during the cooking of meats/fish. These substances are potent mutagens in the Ames/Salmonella assay and are also carcinogens in laboratory animals. In order to assess the magnitude of the cancer risk posed by their presence in the US diet, we estimated the average intakes of HAs, based on analyses of the concentrations of HAs in cooked foods and data from a dietary survey of the US population and quantified the cancer potencies of the individual compounds using dose-response data from animal bioassays. Measured concentrations of HAs in cooked foods were taken from a major review of the open literature. Only those concentrations that were associated with normal cooking conditions were chosen for use in estimating dietary intakes. The average consumption of HA-bearing foods was determined by analyzing statistically the intakes of 3563 individuals who provided 3 day dietary records in a USDA sponsored random survey of the US population during 1989. Dietary intakes of the five principal HAs in descending order were 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) > 2-amino-9H-pyrido[2,3-b]indole (A alpha C) > 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) > 2-amino-3,4,8-trimethylimidazo[4,5-f]quinoxaline (DiMeIQx) > 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). The carcinogenic potencies, in contrast, were almost the reverse order: IQ > DiMeIQx > MeIQx > PhIP > A alpha C. An upper-bound estimate of the incremental cancer risk is 1.1 x 10(-4), using cancer potencies based on a body surface area basis. Nearly half (46%) of the incremental risk was due to ingestion of PhIP. Consumption of meat and fish products contributed the most (approximately 80%) to total risk.

UI MeSH Term Description Entries
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D003296 Cooking The art or practice of preparing food. It includes the preparation of special foods for diets in various diseases. Cookery
D004032 Diet Regular course of eating and drinking adopted by a person or animal. Diets
D005502 Food Substances taken in by the body to provide nourishment. Foods
D005504 Food Analysis Measurement and evaluation of the components of substances to be taken as FOOD. Analysis, Food,Analyses, Food,Food Analyses
D006358 Hot Temperature Presence of warmth or heat or a temperature notably higher than an accustomed norm. Heat,Hot Temperatures,Temperature, Hot,Temperatures, Hot
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
June 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
October 1994, Environmental health perspectives,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
May 1993, Cancer research,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
January 1991, Advances in experimental medicine and biology,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
September 1988, Mutation research,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
January 1994, Journal of the National Cancer Institute,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
July 1999, Mutation research,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
August 1986, Environmental health perspectives,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
June 1992, Mutation research,
D W Layton, and K T Bogen, and M G Knize, and F T Hatch, and V M Johnson, and J S Felton
January 1999, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
Copied contents to your clipboard!